Navigation Links
SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER FINANCIAL RESULTS
Date:11/12/2013

itiative.

The net loss for the quarter ended September 30, 2013 was $0.09 per share, compared to $0.05 per share for the quarter ended September 30, 2012.  The net loss for the nine months ended September 30, 2013 was $0.22 per share compared to $0.17 per share for the nine months ended September 30, 2012.

Cash Status:"Senomyx's balance sheet includes approximately $36 million in cash and we have no debt.  In addition, we have significant sources of funding from our existing collaborators," stated Tony Rogers, Senior Vice President and Chief Financial Officer.  "We continue to be well-positioned from a cash flow standpoint to achieve our discovery, development and commercialization objectives, and we have no plans to raise money through the issuance of equity or debt," Rogers said.

In addition to its quarter-end cash balance, the Company has committed and potential sources of cash including the following:

  • $18 million from current collaborators for license fees and research and development funding
  • $30 million in potential milestone payments under current collaborations
  • $18 million related to collaboration extension options
  • 2013 Guidance: "Expenditures for 2013 are tracking favorably toward the low end of our guidance range.  Commercial revenues were lower than anticipated in the third quarter, primarily due to the fact that collaborator sales of certain flavor products did not achieve our collaborators' forecasts, combined with a reduction of minimum annual royalty payments associated with the reacquisition of rights for S807.  Looking forward, we believe our collaborators should be able to provide more accurate estimates as sales patterns are established and there are more repeat orders following product introductions.  Regarding 2013 development revenues, certain milestone revenues previously anticipated in the fourth quarter are now expected in the first quarter
    '/>"/>

    SOURCE Senomyx
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related biology technology :

    1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
    2. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
    3. SENOMYX AND FIRMENICH ANNOUNCE AMENDMENT OF THEIR SWEET TASTE PROGRAM AGREEMENT
    4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 12TH ANNUAL NEEDHAM HEALTHCARE CONFERENCE
    5. SENOMYX ANNOUNCES CORPORATE UPDATE AND FIRST QUARTER FINANCIAL RESULTS
    6. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE
    7. SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER FINANCIAL RESULTS
    8. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE MIDWEST IDEAS INVESTOR CONFERENCE
    9. Senomyx Announces Management Update
    10. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
    11. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... British Columbia , March 2, ... OTCQB: IMLFF), a clinical stage biopharmaceutical company specializing ... announced that Craig Schneider , Chief Executive ... live webcast at VirtualInvestorConferences.com. DATE: Thursday, ... > click the red "register/ watch event ...
    (Date:3/2/2015)... SAN DIEGO , March 2, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics, ... the 2015 Barclays Global Healthcare Conference in Miami, FL at ... Liang , chief executive officer of Pfenex, will ... and business strategy on March 12th at 9:00 am ET. A ...
    (Date:3/2/2015)... SPRINGS, Florida , March 2, 2015 /PRNewswire/ ... science-based pharmaceuticals and healthy whole food nutrition products ... treatments of lifestyle related disorders such as hyperglycemia, ... and health concerns.  Nutraceutical and Biotech Companies in ... ), Amira Nature Foods Ltd. (NYSE: ...
    (Date:3/2/2015)... YORK , March 2, 2015 ... scroll to bottom.   Moments ago, Analysts ... including Sunshine Heart (NASDAQ: SSH ), ... ), Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... ). Analysts Review provides a single unified platform for investors, ...
    Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4
    ... Gaining a first-cycle,approval for a new molecular ... incremental revenue on average, according to a new ... International (Nasdaq: PRXL ),and leading global life ... According to the PAREXEL Consulting,analysis, 60 percent of ...
    ... how the world communicates, and how we power ... source: nanotechnology. According to a just-released podcast and ... (PEN), nanotechnology will be central to developing advanced, ... , In the latest installment of the ...
    ... at the National Institute of Standards and Technology ... and the University of Colorado (CU) at Boulder, ... significantly reducing the uncertainty in delicate measurements of ... speed and precision of quantum computing and communications ...
    Cached Biology Technology:PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 2PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 3PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 4PAREXEL Consulting Quantifies Speed to Market: First-Cycle Approval for NME Produces $640 Million in Incremental Revenue on Average 5First tunable, 'noiseless' amplifier may boost quantum computing, communications 2
    (Date:3/2/2015)... , March 2, 2015 Synaptics Inc. ... of human interface solutions, today announced a new ... designed to enable rapid and secure transactions and ... for gaming is a turnkey solution providing mouse ... to quickly integrate fingerprint ID solutions into their ...
    (Date:3/2/2015)... 2, 2015  Businesses have a new option ... Tharon Rankins Enterprises has announced the launch of ... way for businesses to protect their customers, personal ... Beconux is a biometric transaction processing ... similarly to an ATM machine, the new system ...
    (Date:3/2/2015)... , March 2, 2015   Neurotechnology , ... today introduced the SentiGaze Software Development Kit ... create applications that use off-the-shelf webcams to track eye ... gazes at a monitor. Heatmaps can be used for ... effectiveness of online advertising. The SDK can also be ...
    Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3Personal Data Protection Company Launches New Product 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3
    ... Enough has been written and said about "platinum" open access ... models. However, comparatively little has been seen of its practical ... journals in Zoology Deutsche Entomologische Zeitschrift and ... into the future by joining the journal publishing platform of ...
    ... NY. (Dec. 18, 2013) Hepatocyte (liver ... acute liver failure, either for liver regeneration or ... the viability and functional aspects of hepatocytes has ... In an effort to improve both the viability ...
    ... Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) ... warmer Atlantic are now reproducing in Arctic waters to the ... shift of the Arctic zooplankton community, scientists report in the ... victims of this "Atlantification" are likely to be marine birds, ...
    Cached Biology News:2 of the oldest German journals in Zoology go for 'platinum' open access 2Liver cells benefit from mesenchymal stem cell co-culture prior to transplantation 2New actors in the Arctic ecosystem 2New actors in the Arctic ecosystem 3
    Rab 3 Immunogen: Synthetic peptide corresponding to the N-terminal region of Rab 3 protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
    Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
    ... to LYZL6 ( Abpromise for ... Antigen: Synthetic peptide: DWLCL AFVE ... corresponding to amino acids 46-100 of ... Gene ID: 57151 ...
    Mouse monoclonal [DJR3] to DcR1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
    Biology Products: